Can blood and physical tests before transplant predict non-relapse mortality

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study looks for signals in blood tests, including CXCL9, and physical assessments conducted before stem cell transplant or cell therapy to see if they can predict non-relapse mortality. Participants are adults planned for SCTCT and will be observed to identify potential predictors. The analysis aims to identify factors that could help stratify risk and guide clinical decisions.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* patients \>18 year old
* patients planned for SCTCT

Exclusion Criteria:

* Pregnancy
* prisoners
* Patients with a serious medical or psychiatric illness likely to interfere with participation in this clinical study

Where it's running

• Henry Ford Health
  Detroit, Michigan, United States Recruiting

Study contacts

• Study coordinator: Shatha Farhan, MD
• Email: sfarhan1@hfhs.org
• Phone: 3137133910

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Testing an ICU time-series model to predict mortality at a major hospital

  We will see if a pre-trained time-series model can accurately forecast outcomes for ICU patients using real-world data.

  Recruiting Peking University People's Hospital · Beijing, Beijing Municipality · NCT07795450

• Prediction score for death or lung transplant in emphysema caused by alpha-1 antitrypsin deficiency

  This study tests a new prediction tool to identify people with emphysema due to alpha-1-antitrypsin deficiency who are at high risk of death or needing a lung transplant.

  Recruiting at 4 sites University Hospital, Bordeaux · Bron and 3 other locations · NCT07715617

• Lung ultrasound and lactate at discharge to predict 30-day outcomes after acute heart failure

  We’re testing whether a combination of lung ultrasound and blood lactate at discharge can help predict who will be readmitted or die within 30 days after leaving the hospital for acute heart failure.

  Recruiting University of Monastir · Monastir, Monastir Governorate · NCT07345156

• What predicts death in the ICU? Analyzing APACHE II in Colombian patients

  This study tests how well the APACHE II score predicts ICU mortality in adults treated at a Colombian hospital.

  Recruiting Hospital Departamental de Villavicencio · Villavicencio, Meta Department · NCT07249749

• Chloride Imbalance in Very Preterm Infants

  This study looks to see if abnormal blood chloride in the first 4–6 weeks of life is linked to death or long-term lung problems in babies born very early.

  Recruiting Kanuni Sultan Suleyman Training and Research Hospital · Istanbul, Turkey · NCT06940856

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.